Published in Int J Chron Obstruct Pulmon Dis on June 06, 2014
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. Int J Chron Obstruct Pulmon Dis (2016) 0.91
Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management. Int J Chron Obstruct Pulmon Dis (2015) 0.88
The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep (2015) 0.82
Value of systematic intervention for chronic obstructive pulmonary disease in a regional Japanese city based on case detection rate and medical cost. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease. BMC Pulm Med (2015) 0.79
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Laryngopharyngeal reflux COPD to uncover reflux and columnar lined esophagus. Int J Chron Obstruct Pulmon Dis (2015) 0.79
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries. PLoS One (2016) 0.78
The disease burden of chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis (2016) 0.78
Analysis of pulmonary function test results in a health check-up population. J Thorac Dis (2015) 0.77
Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations. Ann Thorac Med (2015) 0.75
Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Do symptom-based questions help screen COPD among Chinese populations? Sci Rep (2016) 0.75
A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Emphysema induced by elastase enhances acute inflammatory pulmonary response to intraperitoneal LPS in rats. Int J Exp Pathol (2016) 0.75
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res (2017) 0.75
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med (2006) 49.95
Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care (1986) 22.65
Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) (2008) 12.08
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax (1999) 8.63
Development and testing of a short form of the patient activation measure. Health Serv Res (2005) 8.26
Development and first validation of the COPD Assessment Test. Eur Respir J (2009) 8.06
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics (1993) 7.19
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J (2006) 6.34
Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet (2005) 5.61
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J (2000) 5.54
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax (2003) 4.02
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J (2002) 4.01
COPD in Japan: the Nippon COPD Epidemiology study. Respirology (2004) 2.81
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax (2004) 2.78
Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology (2011) 2.65
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax (2009) 2.27
Economic analysis of the Confronting COPD survey: an overview of results. Respir Med (2003) 1.93
Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 1.73
Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics (2006) 1.61
Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med (2011) 1.54
Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes (2006) 1.49
The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc (2009) 1.40
COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health (2011) 1.39
Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax (1994) 1.36
Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med (2011) 1.25
Chronic obstructive pulmonary disease and exacerbations: patient insights from the global Hidden Depths of COPD survey. BMC Pulm Med (2013) 1.14
Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits. J Epidemiol Community Health (2009) 1.11
Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more. Int J Chron Obstruct Pulmon Dis (2011) 1.10
The burden of chronic obstructive pulmonary disease. Respir Med (2002) 1.10
COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med (2012) 1.06
Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med (2012) 0.98
The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med (2012) 0.95
Non-smoking-related chronic obstructive pulmonary disease: a neglected entity? Respirology (2012) 0.92
Overlap Between Asthma and COPD: Where the Two Diseases Converge. Allergy Asthma Immunol Res (2010) 0.90
Patterns of care for COPD by Japanese physicians. Respirology (2005) 0.90
[Chronic obstructive pulmonary disease (COPD) burden in Japan--confronting COPD Japan survey]. Nihon Kokyuki Gakkai Zasshi (2007) 0.84
Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world. Int J Chron Obstruct Pulmon Dis (2012) 1.13
Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries. Int J Chron Obstruct Pulmon Dis (2014) 0.96
Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. Int J Chron Obstruct Pulmon Dis (2016) 0.91
Continuing to confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management. Int J Chron Obstruct Pulmon Dis (2015) 0.88
Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries. PLoS One (2016) 0.78
Maternal Malaria and Malnutrition (M3) initiative, a pooled birth cohort of 13 pregnancy studies in Africa and the Western Pacific. BMJ Open (2016) 0.75
The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations. Int J Chron Obstruct Pulmon Dis (2017) 0.75